Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Rhoen Klinikum AG's Enterprise Value is $762 Mil.
Rhoen Klinikum AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil. Therefore, Rhoen Klinikum AG's EV-to-FCF for today is .
The historical rank and industry rank for Rhoen Klinikum AG's EV-to-FCF or its related term are showing as below:
RHKJF'
s EV-to-FCF Range Over the Past 10 Years
Min: -339.18 Med: -17.51 Max: 1531.21
Current: -16.58
During the past 13 years, the highest EV-to-FCF of Rhoen Klinikum AG was 1531.21. The lowest was -339.18. And the median was -17.51.
RHKJF's EV-to-FCF is ranked worse than 100% of 404
companies
in the Healthcare Providers & Services industry
Industry Median: 17.91
vs RHKJF: -16.58
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Rhoen Klinikum AG (OTCPK:RHKJF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Rhoen Klinikum AG's PE Ratio (TTM) for today is calculated as:
Rhoen Klinikum AG's share price for today is $15.30.
Rhoen Klinikum AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.698.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Rhoen Klinikum AG EV-to-FCF Related Terms
Rhoen Klinikum AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's EV-to-FCF falls into.
Rhoen Klinikum AG's current Enterprise Value is $762 Mil.
Rhoen Klinikum AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Rhoen Klinikum AG (RHKJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued.
The current stock price of $15.30 is trading 3.3% below its estimated GF Value™ of $15.83.
Key valuation signals for RHKJF:
EV-to-FCF:
GF Value™: $15.83 vs. price of $15.30 (3.3% below fair value)
No single metric tells the full story. See the RHKJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
77GF Score
Get the complete analysis for RHKJF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RHKJF has been successfully added to your 
